562 results on '"Kulkarni, Roshni"'
Search Results
2. A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial
3. Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD
4. Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults
5. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
6. Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
7. First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results
8. Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations
9. Clinical and treatment characteristics of infants and toddlers less than two years of age with hemophilia
10. Featured Cover
11. A Post Hoc Analysis of Previously Untreated Patients With Severe Hemophilia A Who Developed Inhibitors in PUPs A-LONG
12. Quality of Life in Female Adolescents with Bleeding Disorders
13. The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding
14. The current challenges faced by people with hemophilia B
15. Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial
16. Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B
17. The current challenges faced by people with hemophilia B.
18. Congenital and acquired disorders of coagulation
19. Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study
20. Clinical perspectives of emerging pathogens in bleeding disorders
21. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate
22. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science
23. Post hoc longitudinal assessment of efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
24. A Retrospective Analysis of the American Thrombosis and Hemostasis Network Dataset Describing Outcomes of Dental Extractions in Persons with Hemophilia
25. Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
26. Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
27. Depression and anxiety in persons with Von Willebrand disease
28. Mortality Trends Among Persons with Hemophilia in the United States, 2000-2021
29. Efficacy of Efanesoctocog Alfa on Pain in Patients with Hemophilia A: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A
30. Clinical Characteristics Impacting Health-Related Quality of Life in Persons with Von Willebrand Disease
31. Driving Change: Improving Diagnosis and Awareness of Heavy Menstrual Bleeding and Bleeding Disorders in Women and Girls Among Healthcare Providers
32. Clinical and Treatment Characteristics of Infants and Toddlers Less Than Two Years of Age with Hemophilia: A Report from the Community Counts Registry
33. Multicenter, Randomized Crossover Trial Comparing Recombinant Von Willebrand Factor and Tranexamic Acid for Heavy Menstrual Bleeding in Von Willebrand Disease
34. Characterization of Bleeding and Laboratory Phenotype of Carriers of Hemophilia and Trends of Utilization of Factor Concentrates and Hemostatic Therapies: Analysis of the National Athndataset
35. Hemophilia and Related Conditions
36. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
37. Differences in Thrombotic Risk Factors in Black and White Women with Adverse Pregnancy Outcome
38. Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia—Hematology Utilization Group Study Part VII (HUGS VII)
39. Depression and anxiety in persons with Von Willebrand disease.
40. Hemophilia and Related Conditions
41. Quality of life in a large multinational haemophilia B cohort (The B‐Natural study) – Unmet needs remain
42. Efanesoctocog Alfa Half-Life and Clearance Are Independent of von Willebrand Factor in Severe Hemophilia A: A Post Hoc Analysis from Phase 1/2a Studies
43. Depression and Anxiety in Persons with Von Willebrand Disease
44. A Cross-Sectional Study of the American Thrombosis and Hemostasis Network Dataset for Outcomes of Dental Extractions in People with Hemophilia
45. Challenges in the management of haemophilia on transition from adolescence to adulthood
46. Improving care and treatment options for women and girls with bleeding disorders
47. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
48. Risk Factors for Joint Bleeding in Severe Hemophilia a and B: Analysis of the Community Counts Longitudinal Surveillance Cohort
49. Hemophilia and Related Conditions
50. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.